C-MER Medical Holdings Limited (HKG:3309)
Hong Kong · Delayed Price · Currency is HKD 1.490
+0.040 (2.76%)
At close: Feb 13, 2026
C-MER Medical Holdings Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1,935 | 1,913 | 1,924 | 1,732 | 1,113 | 699.55 | |
Revenue Growth (YoY) | 2.04% | -0.56% | 11.09% | 55.67% | 59.04% | 21.40% |
Cost of Revenue | 1,333 | 1,316 | 1,305 | 1,284 | 754.35 | 505.47 |
Gross Profit | 601.68 | 596.9 | 618.96 | 447.7 | 358.23 | 194.08 |
Selling, General & Admin | 484.88 | 475.98 | 502.73 | 472.12 | 360.56 | 209.16 |
Other Operating Expenses | -7.68 | -8.09 | -8.41 | -28.65 | -10.58 | -12.91 |
Operating Expenses | 477.31 | 468.01 | 494.45 | 443.47 | 349.98 | 196.25 |
Operating Income | 124.38 | 128.89 | 124.51 | 4.22 | 8.25 | -2.17 |
Interest Expense | -24.56 | -23.66 | -18.12 | -19.66 | -13 | -10.35 |
Interest & Investment Income | 15.67 | 14.57 | 19.89 | 7.11 | 4.48 | 5.06 |
Earnings From Equity Investments | -2.01 | -0.98 | 3.16 | 37.8 | 10.65 | -0.28 |
Currency Exchange Gain (Loss) | -0.68 | -0.45 | -3.05 | -7.06 | 4.44 | 10.25 |
EBT Excluding Unusual Items | 112.81 | 118.38 | 126.39 | 22.42 | 14.83 | 2.5 |
Gain (Loss) on Sale of Investments | 1.72 | 3.44 | -10.74 | -33.22 | 16.71 | 0.04 |
Gain (Loss) on Sale of Assets | 1.16 | -1.43 | -0.12 | -0.43 | -5.12 | -0.04 |
Asset Writedown | -200.56 | -199.98 | -2.5 | - | - | - |
Other Unusual Items | 14.88 | 2.59 | 11.24 | - | 0.45 | - |
Pretax Income | -69.22 | -76.22 | 124.27 | -11.23 | 26.88 | 2.5 |
Income Tax Expense | 31.58 | 32.09 | 37.93 | 35 | 10.65 | 10.92 |
Earnings From Continuing Operations | -100.8 | -108.31 | 86.34 | -46.23 | 16.23 | -8.41 |
Minority Interest in Earnings | -15.19 | -26.85 | -24.34 | 24.35 | 5.63 | 2.17 |
Net Income | -115.98 | -135.16 | 62 | -21.88 | 21.86 | -6.25 |
Net Income to Common | -115.98 | -135.16 | 62 | -21.88 | 21.86 | -6.25 |
Shares Outstanding (Basic) | 1,221 | 1,233 | 1,256 | 1,233 | 1,148 | 1,104 |
Shares Outstanding (Diluted) | 1,221 | 1,233 | 1,256 | 1,233 | 1,151 | 1,104 |
Shares Change (YoY) | -2.00% | -1.77% | 1.82% | 7.16% | 4.22% | 3.02% |
EPS (Basic) | -0.10 | -0.11 | 0.05 | -0.02 | 0.02 | -0.01 |
EPS (Diluted) | -0.10 | -0.11 | 0.05 | -0.02 | 0.02 | -0.01 |
Free Cash Flow | 136.82 | 124.51 | 245.67 | 75.86 | 26.26 | 78.1 |
Free Cash Flow Per Share | 0.11 | 0.10 | 0.20 | 0.06 | 0.02 | 0.07 |
Dividend Per Share | 0.020 | 0.020 | - | - | - | 0.020 |
Gross Margin | 31.09% | 31.20% | 32.17% | 25.85% | 32.20% | 27.74% |
Operating Margin | 6.43% | 6.74% | 6.47% | 0.24% | 0.74% | -0.31% |
Profit Margin | -5.99% | -7.07% | 3.22% | -1.26% | 1.97% | -0.89% |
Free Cash Flow Margin | 7.07% | 6.51% | 12.77% | 4.38% | 2.36% | 11.16% |
EBITDA | 193.31 | 202.46 | 204.02 | 92.28 | 60.03 | 40.61 |
EBITDA Margin | 9.99% | 10.58% | 10.60% | 5.33% | 5.40% | 5.80% |
D&A For EBITDA | 68.93 | 73.57 | 79.51 | 88.06 | 51.78 | 42.78 |
EBIT | 124.38 | 128.89 | 124.51 | 4.22 | 8.25 | -2.17 |
EBIT Margin | 6.43% | 6.74% | 6.47% | 0.24% | 0.74% | -0.31% |
Effective Tax Rate | - | - | 30.53% | - | 39.61% | 435.94% |
Advertising Expenses | - | 131.02 | 145.61 | 125.65 | 125.66 | 69.41 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.